Ivabradine in stable coronary artery disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.Clinical cardiology · 2021
   Pooled it
2. Accelerated physiologic pacing in patients with heart failure with preserved ejection fraction: An argument in support of therapeutic heart rate modulation.Heart rhythm O2 · 2024
   Article
3. Ivabradine in patients with acute ST-elevation myocardial infarction: a meta-analysis of randomized controlled trials.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023
   Review
4. Heart rate, mortality, and the relation with clinical and subclinical cardiovascular diseases: results from the Gutenberg Health Study.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
   Article
5. Big data from electronic health records for early and late translational cardiovascular research: challenges and potential.European heart journal · 2018
   Review
6. Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study.JAMA cardiology · 2018
   Article
7. Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.World journal of diabetes · 2018
   Review
8. Neprilysin inhibition: A brief review of past pharmacological strategies for heart failure treatment and future directions.Cardiology journal · 2016
   Review
9. Vascular endothelial dysfunction and pharmacological treatment.World journal of cardiology · 2015
   Review
10. Ivabradine: pre-clinical and clinical evidence in the setting of ventricular arrhythmias.Hippokratia
    Review

Corrections and comments

• Comment on
  Ivabradine in stable coronary artery disease without clinical heart failure.2014
• Comment on
  Ivabradine in stable coronary artery disease.2014

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as